Verkauf durch Sack Fachmedien

Stevens

Drug Policy Constellations

The Role of Power and Morality in the Making of Drug Policy in the UK

Medium: Buch
ISBN: 978-1-5292-3132-8
Verlag: Bristol University Press
Erscheinungstermin: 30.01.2024
Lieferfrist: bis zu 10 Tage
How is UK drugs policy made, and why does it so often seem irrational when considering what works in reducing drug-related harms?
This book explains how the concept of drug policy constellations – the loosely concerted policy actors with shared moral commitments that influenced policy outcomes – explains why there is no such thing as 'evidence-based' drug policy. Drawing on his participation in high-level policy discussions, and a novel approach to policy analysis, Stevens presents three recent cases involving key issues in UK illicit drug policy – medical cannabis, drug-related deaths and the government’s 10-year drug strategy.

Produkteigenschaften


  • Artikelnummer: 9781529231328
  • Medium: Buch
  • ISBN: 978-1-5292-3132-8
  • Verlag: Bristol University Press
  • Erscheinungstermin: 30.01.2024
  • Sprache(n): Englisch
  • Auflage: 1. Auflage 2024
  • Produktform: Gebunden, Hardback (Adhesive)
  • Gewicht: 520 g
  • Seiten: 192
  • Format (B x H x T): 159 x 236 x 19 mm
  • Ausgabetyp: Kein, Unbekannt

Autoren/Hrsg.

Autoren

Stevens, Alex

1. An Introduction to Drug Policy Constellations
Part I: Contexts, Concepts and Methods for Studying Drug Policy Constellations
2. Facts and Narratives of the UK Drug Policy Context
3. Power and Morality in Policy Making
4. Policy Constellation: A Critical Realist Approach
5. Studying Policy Constellations in the Real World
Part II: Morality and Power in UK Drug Policy Constellations
6. Moralities in Action: The Ethico-Political Bases of UK Drug Policy
7. Mapping UK Drug Policy Constellations
8. Power in UK Drug Policy Constellations
Part III: Cases in Drug Policy Making in the UK
9. The Legalisation of Medical Cannabis
10. Responses to the Drug Deaths Crisis: Explaining Differences at UK and Scottish Levels
11. The UK’s Ten-Year Drug Strategy
12. A Retroductive Conclusion